Rigel Pharmaceuticals regains rights as Lilly terminates license deal

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. ACN
3. NVDA
4. APGE
5. USO
6. GOOGL
7. MU
8. HOOD
9. DFTX
10. MSFT

Go back to Rigel Pharmaceuticals regains rights as Lilly terminates license deal
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1106.31 +7.74 (0.70%)
Previous Close $1098.57    52 Week High $88.16 
Open $1112.24    52 Week Low $67.88 
Day High $1119.45    P/E 256.09 
Day Low $1093.15    EPS $4.32 
Volume 1,720,796       

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) Delayed: 36.32 +3.41 (10.36%)
Previous Close $32.91    52 Week High $4.38 
Open $33.65    52 Week Low $1.88 
Day High $36.53    P/E N/A 
Day Low $33.64    EPS $-1.12 
Volume 410,402